DUBLIN, October 3, 2017 /PRNewswire/ --
The "Global Vascular Stents Market 2017-2021" report has been added to Research and Markets' offering.
The global vascular stents market to grow at a CAGR of 7.22% during the period 2017-2021.
Global Vascular Stents Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The latest trend gaining momentum in the market is Technological advances in stents. The narrowing and blocking of vessels due to disease or injury can be prevented with the use of stents in coronary and peripheral procedures. The market value will increase with the advances such as biodegradable materials and bifurcated stents. The bifurcated lesions found in coronary vessels can be treated with the help of bifurcated stents. The pricing of these stents can be 30% higher than the conventional stents. The price difference is expected to reduce over time. The global vascular stents market will see a further growth with advances in bifurcated stents.
According to the report, one of the major drivers for this market is Increasing burden of vascular diseases. The increasing burden of vascular diseases such as CAD, PAD, CVD, and neurovascular diseases will increase the patient pool. Factors such as diabetes, older population, obesity, and hypertension are the major factors leading to vascular diseases. The impact of vascular diseases can be higher in the developing nations due to low awareness among people. Many people are even not aware of the preventive measures to be taken for specific vascular diseases. The governments and vendors in developing nations are focusing on increasing the awareness among people.
Further, the report states that one of the major factors hindering the growth of this market is Stringent regulations for product approval. The Food and Drugs Administration (FDA) has set strict guidelines for the development of new products. The products should go through certain trial, testing, and validation. The process is time consuming and large amount is invested by the sponsor for the approval and launch of a product in the market.
Failure at any stage of the trial can be a loss of time and money for the sponsor. Regulatory framework for vascular stents is strict. Regulatory bodies have imposed strict labeling requirement, pre-market approval, and medical device reporting and launching of product. These devices are considered to be highly-risky, and need to go through all the safety examinations to prove their medical efficacy before approval.
- Boston Scientific
- Cardinal Health
- Cook Medical
Other prominent vendors
- B. Braun
- Biosensors International
- Fortimedix Surgical
- Meril Life Sciences
- MicroPort Scientific
- ?SORIN GROUP
- Terumo Medical
- W. L. Gore & Associates
Key Topics Covered:
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Research Methodology
Part 04: Introduction
Part 05: Market Landscape
Part 06: Market Segmentation By Product
Part 07: Market Segmentation By End-User
Part 08: Geographical Segmentation
Part 09: Decision Framework
Part 10: Drivers And Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Key Vendor Analysis
Part 14: Appendix
For more information about this report visit https://www.researchandmarkets.com/research/jsf39z/global_vascular
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets